Diagnosis and Management of Thyrotoxicosis

  • Edith T. de los Santos
  • Ernest L. Mazzaferri
Part of the Contemporary Internal Medicine book series (COIM, volume 3)

Abstract

A 54-year-old housewife was seen in consultation at the Ohio State University Thyroid Clinic because of weight loss. Twelve years previously, she had experienced substantial weight loss and other symptoms that had been attributed to Graves’ disease which was treated with 131I resulting in prompt resolution of her symptoms. She remained well until four months prior to her present consultation when she was hospitalized for pneumonia from which she recovered quickly; nonetheless, since having pneumonia she had lost 25 pounds despite having a good appetite. In addition, she had recently been developing symptoms of easy fatigability, palpitations, nervousness, heat intolerance, muscle weakness, and hair loss.

Keywords

Thyroid Hormone Antithyroid Drug Struma Ovarii Diffuse Goiter Radioactive Iodine Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ingbar SH: Thyrotoxicosis: Classification and manifestations, in Ingbar SH, Braverman LE (eds): Werner’s The Thyroid: A Fundamental and Clinical Text, ed 5. Philadelphia, JB Lippincott Co., 1986, pp 809–810.Google Scholar
  2. 2.
    de los Santos ET, Mazzaferri EL: Thyrotoxicosis. Results and risks of current therapy. Postgrad Med. 1990 Apr;87(5):277–278,281-286,288,291-294.PubMedGoogle Scholar
  3. 3.
    Nordyke RA, Gilbert FT, Harada AS: Graves’ disease. Influence of ages on clinical findings. Arch Intern Med. 1988 Mar;148:626–631.PubMedCrossRefGoogle Scholar
  4. 4.
    McKenzie JM, Zakarija M: Hyperthyroidism, in: DeGroot LJ (ed): Endocrinology, ed 2. Philadelphia, WB Saunders Co, 1989, pp 846–682.Google Scholar
  5. 5.
    Mazzaferri EL: The thyroid, Mazzaferri EL (ed): Textbook of Endocrinology ed 3. New York, Medical Examination Publishing, 1986, pp 89–350.Google Scholar
  6. 6.
    Bahn RS, Garrity JA, Bartley GB, et al: Diagnostic evaluation of Graves’ ophthalmopathy. Endocrinol Metab Clin North Am. 1988;17:527–545.PubMedGoogle Scholar
  7. 7.
    de los Santos ET, Stanch GH, Mazzaferri EL: Sensitivity, specificity and cost-effectiveness of sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med. 1989;149:526–532.PubMedCrossRefGoogle Scholar
  8. 8.
    de los Santos ET, Mazzaferri EL: Thyroid function tests. Guidelines for interpretation in common clinical disorders. Postgrad Med. 1989;85:333–352.PubMedGoogle Scholar
  9. 9.
    Larsen PR, Alexander NM, Chopra D, et al: Revised nomenclature for tests of thyroid hormone and thyroid related protein in serum. J Clin Endocrinol Metab. 1987;64:1089–1094.PubMedCrossRefGoogle Scholar
  10. 10.
    Hay ID, Klee GG: Thyroid dysfunction. Endocrinol Clin North Am. 1988;17:473–509.Google Scholar
  11. 11.
    de los Santos ET, Mazzaferri EL: Sensitive thyroid stimulating hormone assays: Clinical applications and limitations. Compr Ther. 1988;14(9):26–33.Google Scholar
  12. 12.
    Zakarija M, McKenzie JM: Pregnancy-associated changes in the thyroid stimulating antibody of Graves’disease and the relationship with neonatal hyperthyroidism. J Clin Endocrinol Metab. 1983;57:1036–1040.PubMedCrossRefGoogle Scholar
  13. 13.
    Tamaki H, Amino N, Aozasa M, et al: Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. Am J Perinatol. 1988 Apr;5:152–158.PubMedCrossRefGoogle Scholar
  14. 14.
    Orgiazzi J, Madec AM, Genetet N, et al: Immunological parameters in Graves’ disease: Are they useful for indication and monitoring of antithyroid drug treatment? Horm Res. 1987;26:131–136.PubMedCrossRefGoogle Scholar
  15. 15.
    Refetoff S: Thyroid function tests and effects of drugs on thyroid function, in DeGroot LJ (ed): Endocrinology, ed 2. Philadelphia, WB Saunders Co, 1989 pp 590–639.Google Scholar
  16. 16.
    Cooper DS: Antithyroid drugs. Engl J Med. 1984;311:1353–1362.CrossRefGoogle Scholar
  17. 17.
    Fenzi G, Hashizume K, Roudebush CP, et al: Changes in thyroid stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab 1979;48:572–576.PubMedCrossRefGoogle Scholar
  18. 18.
    Teng CS, Yeung RTT: Change in thyroid-stimulating antibody activity in Graves’disease treated with anti-thyroid drugs and its relationship to relapse: A prospective study. J Clin Endocrinol Metab. 1980;50:144–147.PubMedCrossRefGoogle Scholar
  19. 19.
    Hanson JS: Propylthiouracil and hepatitis. Two cases and a review of literature. Arch Intern Med. 1984;144:994–996.CrossRefGoogle Scholar
  20. 20.
    Limaye A, Ruffolo PR: Propylthiouracil-induced fatal hepatic necrosis. Am J Gastroenterol. 1987;82:152–154.PubMedGoogle Scholar
  21. 21.
    Leclere J: Anti-thyroid drugs-A rational treatment for Graves’ disease? Horm. Res. 1987;26:125–130.PubMedCrossRefGoogle Scholar
  22. 22.
    Mazzaferri EL, Reynolds JC, Young RL, et al: Propranolol as primary therapy for thyrotoxicosis. Result of a long-term prospective study. Arch Intern Med. 1976;136:50–56.PubMedCrossRefGoogle Scholar
  23. 23.
    Feely J, Peden N: Use of beta-adrenoceptor blocking drugs in hyperthyroidism. Drugs. 1984;27:425–446.PubMedCrossRefGoogle Scholar
  24. 24.
    Kamel N, Upsala AR, Kologlu S, et al: Sodium ipodate in the treatment of toxic diffuse goiter. Short-term or long-term effects on thyrotoxicosis. Rom J Med. 1988;26:99–105.Google Scholar
  25. 25.
    Roti E, Robuschi G, Manfredi A, et al: Comparative effect of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves’ disease. Clin Endocrinol. 1985;22:489–496.CrossRefGoogle Scholar
  26. 26.
    Orgiazzi J: Management of Graves’ hyperthyroidism. Endocrinol Clin North Am. 1987;16:365–389.Google Scholar
  27. 27.
    Goolden AWG, Stewart JSW: Long-term results from graded low-dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol. 1986;24:217–222.CrossRefGoogle Scholar
  28. 28.
    Graham GD, Burman KD: Radioiodine treatment of Graves’disease. An assessment of its possible risks. Ann Intern Med. 1986;105:900–905.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Edith T. de los Santos
  • Ernest L. Mazzaferri

There are no affiliations available

Personalised recommendations